Doorgaan naar inhoud

Trauma en spoedeisende hulp

Management en optimalisatie van hemostase

Antifibrinolytica

Alternatives to allogeneic platelet transfusion. (opent nieuw venster)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Bron‎: Br J Haematol 2016;175(3):381-92.

Geïndexeerd‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (opent nieuw venster)

Antifibrinolytic drugs for acute traumatic injury. (opent nieuw venster)

Ker K, Roberts I, Shakur H, Coats TJ.

Bron‎: Cochrane Database Syst Rev 2015;(5):CD004896.

Geïndexeerd‎: PubMed 25956410

DOI‎: 10.1002/14651858.CD004896.pub4

https://www.ncbi.nlm.nih.gov/pubmed/25956410 (opent nieuw venster)

Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. (opent nieuw venster)

Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE.

Bron‎: JAMA Surg 2013;148(3):218-25.

Geïndexeerd‎: PubMed 23670117

DOI‎: 10.1001/jamasurg.2013.764

https://www.ncbi.nlm.nih.gov/pubmed/23670117 (opent nieuw venster)

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (opent nieuw venster)

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T; CRASH-2 collaborators.

Bron‎: Lancet 2011;377(9771):1096-101, 1101.e1-2.

Geïndexeerd‎: PubMed 21439633

DOI‎: 10.1016/S0140-6736(11)60278-X

https://www.ncbi.nlm.nih.gov/pubmed/21439633 (opent nieuw venster)

Recombinante geactiveerde factor VII (rFVIIa)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (opent nieuw venster)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Bron‎: Transfusion 2009;49 Suppl 5:240S-7S.

Geïndexeerd‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (opent nieuw venster)

Coagulatiefactorconcentraten

The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. (opent nieuw venster)

Innerhofer P, Westermann I, Tauber H, Breitkopf R, Fries D, Kastenberger T, El Attal R, Strasak A, Mittermayr M.

Bron‎: Injury 2013;44(2):209-16.

Geïndexeerd‎: PubMed 23000050

DOI‎: 10.1016/j.injury.2012.08.047

https://www.ncbi.nlm.nih.gov/pubmed/23000050 (opent nieuw venster)

Desmopressine

Desmopressin is a transfusion sparing option to reverse platelet dysfunction in patients with severe traumatic brain injury. (opent nieuw venster)

Furay EJ, Daley MJ, Satarasinghe P, Lara S, Aydelotte JD, Teixeira PG, Coopwood TB, Ali S, Brown CVR

Bron‎: J Trauma Acute Care Surg 2020;88(1):80-6.

Geïndexeerd‎: PubMed 31688782

DOI‎: 10.1097/TA.0000000000002521

https://www.ncbi.nlm.nih.gov/pubmed/31688782 (opent nieuw venster)

Visco-elastische tests ter vaststelling van chirurgische of coagulopathische bloedingen

Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy. (opent nieuw venster)

Brenni M, Worn M, Brüesch M, Spahn DR, Ganter MT.

Bron‎: Acta Anaesthesiol Scand 2010;54(1):111-7.

Geïndexeerd‎: PubMed 19860752

DOI‎: 10.1111/j.1399-6576.2009.02132.x

https://www.ncbi.nlm.nih.gov/pubmed/19860752 (opent nieuw venster)